ATE344264T1 - Porphyrin-verbindung, deren albumin- einschlussverbindung und künstlicher sauerstoffträger - Google Patents

Porphyrin-verbindung, deren albumin- einschlussverbindung und künstlicher sauerstoffträger

Info

Publication number
ATE344264T1
ATE344264T1 AT04005777T AT04005777T ATE344264T1 AT E344264 T1 ATE344264 T1 AT E344264T1 AT 04005777 T AT04005777 T AT 04005777T AT 04005777 T AT04005777 T AT 04005777T AT E344264 T1 ATE344264 T1 AT E344264T1
Authority
AT
Austria
Prior art keywords
compound
porphyrin
oxygen carrier
albumin
artificial oxygen
Prior art date
Application number
AT04005777T
Other languages
English (en)
Inventor
Elshun Tsuchida
Teruyuki Komatsu
Akito Nakagawa
Naomi Ohmichi
Original Assignee
Nipro Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nipro Corp filed Critical Nipro Corp
Application granted granted Critical
Publication of ATE344264T1 publication Critical patent/ATE344264T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Diabetes (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT04005777T 2003-03-14 2004-03-11 Porphyrin-verbindung, deren albumin- einschlussverbindung und künstlicher sauerstoffträger ATE344264T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003069760A JP3945428B2 (ja) 2003-03-14 2003-03-14 ポルフィリン化合物、そのアルブミン包接化合物および人工酸素運搬体

Publications (1)

Publication Number Publication Date
ATE344264T1 true ATE344264T1 (de) 2006-11-15

Family

ID=32866679

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04005777T ATE344264T1 (de) 2003-03-14 2004-03-11 Porphyrin-verbindung, deren albumin- einschlussverbindung und künstlicher sauerstoffträger

Country Status (5)

Country Link
US (3) US20040180837A1 (de)
EP (1) EP1466915B1 (de)
JP (1) JP3945428B2 (de)
AT (1) ATE344264T1 (de)
DE (1) DE602004002975T2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006232818A (ja) * 2005-01-25 2006-09-07 Nipro Corp ポルフィリン金属錯体とアルブミンとの包接化合物
CN1810250A (zh) * 2005-01-25 2006-08-02 尼普洛株式会社 卟啉金属络合物与清蛋白的包合物
EP1704870A1 (de) * 2005-03-25 2006-09-27 Nipro Corporation Verwendung von Eisenverbindungen als Radiosensitizer
CN109475511A (zh) 2016-05-19 2019-03-15 高等教育联邦系统-匹兹堡大学 还原态氧载体及其用于治疗碳氧血红蛋白血症的用途
JP2019099488A (ja) * 2017-11-30 2019-06-24 小林製薬株式会社 ペプチド及びその利用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59164791A (ja) 1983-03-09 1984-09-17 Hidetoshi Tsuchida ２位に置換基を有する５，１０，１５，２０―テトラ〔α，α，α，α―ｏ―（ピバラミド）フェニル〕ポルフィリン化合物
JPS59162924A (ja) 1983-03-09 1984-09-13 Hidetoshi Tsuchida 酸素吸脱着剤
JP3312953B2 (ja) 1993-03-22 2002-08-12 財団法人生産開発科学研究所 ２位置側鎖を有するテトラフェニルポルフィリン金属錯体及びその製造法
JP3428225B2 (ja) 1995-04-28 2003-07-22 三菱ウェルファーマ株式会社 ポルフィリン金属錯体−アルブミン包接化合物及び酸素運搬体
JP3432190B2 (ja) 1999-11-09 2003-08-04 英俊 土田 ポルフィリン金属錯体−アルブミン多量体包接化合物、及びそれを有効成分とする酸素輸液剤

Also Published As

Publication number Publication date
US7754879B2 (en) 2010-07-13
US7595394B2 (en) 2009-09-29
DE602004002975T2 (de) 2007-04-12
US20090182125A1 (en) 2009-07-16
US20060003923A1 (en) 2006-01-05
EP1466915A1 (de) 2004-10-13
JP2004277329A (ja) 2004-10-07
DE602004002975D1 (de) 2006-12-14
US20040180837A1 (en) 2004-09-16
EP1466915B1 (de) 2006-11-02
JP3945428B2 (ja) 2007-07-18

Similar Documents

Publication Publication Date Title
LUC00153I1 (de)
DE602005005240D1 (de) 4'-C-substituierte 2-Haloadenosinderivate
BRPI0317696B8 (pt) composição para branqueamento
BR0313342A (pt) Método de preparação de compostos
DE60230890D1 (de) Indolizine als kinaseproteinhemmer
DE60234164D1 (de) Neues a-liponsäurederivat und dessen verwendung
IN2012DN02609A (de)
DE60234690D1 (de) Neue verbindungen als entzündungshemmende, immunmodulierende und antiproliferative mittel
ATE407967T1 (de) Nukleierungsmittel
DE60132171D1 (de) Tocopherole, tocotrienole, andere chrome und seitenketten-derivate und ihre verwendung
BRPI0512310A (pt) compostos quìmicos
SI1975164T1 (sl) Oktahidrobenzimidazolonske spojine kot analgetiki
EP1304121A4 (de) Inhibitoren der koerpergewichtszunahme
MXPA04009476A (es) Compuestos de (tiazol-4,2-disustituidos-5-il)amina como inhibidores de la pde7.
ATE344264T1 (de) Porphyrin-verbindung, deren albumin- einschlussverbindung und künstlicher sauerstoffträger
TW200517117A (en) Stabilized compositions containing an oxygen-labile active agent
AU2002342498A1 (en) Organic compounds
DE602005009707D1 (de) Metallkomplexierte phospholderivate und pharmazeutische verwendungen dafür
ATE381544T1 (de) 1-aryl-4-cycloalk(en)ylpyrazole als antiparasitäre mittel
DE602004009313D1 (de) Organosiliziumverbindungen und deren verwendung
EP1186616A4 (de) Antifucoidan antikörper
EP1616871A4 (de) Porphyrinverbindung mit biotinylgruppe und deren verwendung
DE60311000D1 (de) Indolderivate und deren verwendung als 5-ht liganden
DE60331100D1 (de) Übergangsmetallkomplex mit diphosphinverbindung als ligand
ATE448198T1 (de) Neue alpha-ketoamidderivate und deren verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties